SCHEMBL28785652

SCHEMBL28785652

O=CC1=NCCc2cc(Br)ccc21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.44
PARP11 Q9NR21 1/20 0.44
SRD5A1 P18405 2/20 0.42
SRD5A2 P31213 1/20 0.42
CYP19A1 P11511 6/20 0.42
CYP11B1 P15538 6/20 0.42
CYP11B2 P19099 6/20 0.42
METAP1 P53582 2/20 0.38
TYMS P04818 1/20 0.38
TDP2 O95551 1/20 0.37
S100A4 P26447 1/20 0.34
ERN1 O75460 1/20 0.34
MAPK10 P53779 2/20 0.34
MAPK14 Q16539 1/20 0.34
SLC2A1 P11166 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL581700 0.75 SRD5A1 (0.45) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL1010625 0.75 MAOA (0.50) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL5128271 0.74 NOS3 (0.55) PARP10PARP11CYP19A1CYP11B1CYP11B2
SCHEMBL31173460 0.72 KDM4E (0.41) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL11812576 0.71 SRD5A1 (0.53) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL16400955 0.71 SRD5A1 (0.49) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL5772636 0.71 PLAU (0.44) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL31219986 0.71 CYP19A1 (0.41) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL19794689 0.71 CYP19A1 (0.41) PARP10PARP11SRD5A1SRD5A2CYP19A1
SCHEMBL2616887 0.71 MAPK10 (0.47) PARP10PARP11MAPK10MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101848896-A Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists WYETH CORP 2010-09-29 CN disclosed